» Articles » PMID: 36315049

Clonal Lineage Tracing Reveals Mechanisms Skewing CD8+ T Cell Fate Decisions in Chronic Infection

Abstract

Although recent evidence demonstrates heterogeneity among CD8+ T cells during chronic infection, developmental relationships and mechanisms underlying their fate decisions remain incompletely understood. Using single-cell RNA and TCR sequencing, we traced the clonal expansion and differentiation of CD8+ T cells during chronic LCMV infection. We identified immense clonal and phenotypic diversity, including a subset termed intermediate cells. Trajectory analyses and infection models showed intermediate cells arise from progenitor cells before bifurcating into terminal effector and exhausted subsets. Genetic ablation experiments identified that type I IFN drives exhaustion through an IRF7-dependent mechanism, possibly through an IFN-stimulated subset bridging progenitor and exhausted cells. Conversely, Zeb2 was critical for generating effector cells. Intriguingly, some T cell clones exhibited lineage bias. Mechanistically, we identified that TCR avidity correlates with an exhausted fate, whereas SHP-1 selectively restricts low-avidity effector cell accumulation. Thus, our work elucidates novel mechanisms underlying CD8+ T cell fate determination during persistent infection and suggests two potential pathways leading to exhaustion.

Citing Articles

The endogenous antigen-specific CD8 T cell repertoire is composed of unbiased and biased clonotypes with differential fate commitments.

Abdullah L, Emiliani F, Vaidya C, Stuart H, Musial S, Kolling F Immunity. 2025; 58(3):601-615.e9.

PMID: 40020673 PMC: 11903169. DOI: 10.1016/j.immuni.2025.02.001.


Functional memory T cells are derived from exhausted clones and expanded by checkpoint blockade.

Raposo C, Yan P, Chen A, Majidi S, Hiam-Galvez K, Satpathy A bioRxiv. 2025; .

PMID: 39990338 PMC: 11844384. DOI: 10.1101/2025.02.10.637523.


CD226 identifies effector CD8 T cells during tuberculosis and costimulates recognition of -infected macrophages.

Shinkawa T, Chang E, Rakib T, Cavallo K, Lai R, Behar S bioRxiv. 2025; .

PMID: 39896604 PMC: 11785225. DOI: 10.1101/2025.01.22.634303.


Epigenetics behind CD8 T cell activation and exhaustion.

Zu H, Chen X Genes Immun. 2024; 25(6):525-540.

PMID: 39543311 DOI: 10.1038/s41435-024-00307-1.


Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7.

Lei X, Xiao R, Chen Z, Ren J, Zhao W, Tang W Proc Natl Acad Sci U S A. 2024; 121(47):e2412120121.

PMID: 39541355 PMC: 11588128. DOI: 10.1073/pnas.2412120121.


References
1.
Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel R, Bairoch A . ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003; 31(13):3784-8. PMC: 168970. DOI: 10.1093/nar/gkg563. View

2.
Zhang D, Wang Q, Wei J, Baimukanova G, Buchholz F, Stewart A . Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J Immunol. 2005; 174(11):6725-31. DOI: 10.4049/jimmunol.174.11.6725. View

3.
Paley M, Kroy D, Odorizzi P, Johnnidis J, Dolfi D, Barnett B . Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science. 2012; 338(6111):1220-5. PMC: 3653769. DOI: 10.1126/science.1229620. View

4.
Lorenz U . SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev. 2009; 228(1):342-59. PMC: 2669678. DOI: 10.1111/j.1600-065X.2008.00760.x. View

5.
Scott A, Dundar F, Zumbo P, Chandran S, Klebanoff C, Shakiba M . TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019; 571(7764):270-274. PMC: 7698992. DOI: 10.1038/s41586-019-1324-y. View